Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Xenon Pharmaceuticals (Nasdaq:XENE) has announced that President Ian Mortimer and CFO Sherry Aulin will participate in fireside chats and one-on-one meetings at upcoming investor conferences. The events include the Guggenheim 4th Annual Immunology and Neurology Day on November 14, the Stifel 2022 Healthcare Conference on November 15, and the Jefferies London Healthcare Conference on November 17. These presentations aim to engage investors and provide insights into the company’s developments in neurology therapeutics. Additional information can be found on their investors' website.

BURNABY, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that Ian Mortimer, Xenon’s President and Chief Executive Officer, along with Sherry Aulin, Xenon’s Chief Financial Officer, will host fireside chat presentations and participate in one-on-one meetings at the following investor conferences:

• Guggenheim 4th Annual Immunology and Neurology Day on Monday, November 14, 2022 with a fireside chat presentation at 10:45 am ET
  
  
• Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 with a fireside chat presentation at 10:20 am ET
  
  
• Jefferies London Healthcare Conference on Thursday, November 17, 2022 with a fireside chat presentation at 10:25 am  GMT (5:25  am  ET)
  

Details about company presentations, webcasts, and other events can be found on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event. The above-listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When will Xenon Pharmaceuticals present at the Guggenheim Immunology and Neurology Day?

Xenon Pharmaceuticals will present at the Guggenheim 4th Annual Immunology and Neurology Day on November 14, 2022, at 10:45 am ET.

What is the schedule for Xenon Pharmaceuticals at the Stifel 2022 Healthcare Conference?

Xenon Pharmaceuticals will have a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, at 10:20 am ET.

Where can I find the webcasts for Xenon Pharmaceuticals' investor presentations?

Webcasts for Xenon Pharmaceuticals' presentations will be posted on their investors' website after the events.

What is the focus of Xenon Pharmaceuticals' product pipeline?

Xenon Pharmaceuticals is focused on developing innovative therapeutics for patients with neurological disorders, particularly in epilepsy.

Who will represent Xenon Pharmaceuticals at the Jefferies London Healthcare Conference?

Ian Mortimer and Sherry Aulin will represent Xenon Pharmaceuticals at the Jefferies London Healthcare Conference on November 17, 2022, at 10:25 am GMT.